Its essential to attend regular check-ups with your healthcare provider to monitor your response to the medication and ensure its continued safety and effectiveness for your specific health condition
For those participating in retatrutide clinical trials, managing side effects is an important part of the treatment experience
Special medical attention is important, among other things, in cases of: existing gastrointestinal conditions type 2 diabetes or other metabolic disorders cardiovascular disease or increased cardiovascular risk regular use of other medications previous intolerance to GLP-1 or GIP/GLP-1 medications unclear symptoms before starting treatment pregnancy, breastfeeding, or plans to become pregnant Patients can find more information about the tolerability of established GLP-1 medications, for example, on our page about side effects of Wegovy with semaglutide
C., Camisa, C., Cheney, P., Pacula, C
While not required, passengers may choose to voluntarily inform TSA officers about their injectable medications at the security checkpoint
Contact your GP within 2448 hours for: Persistent pale or grey stools without jaundice Unexplained changes in stool colour lasting more than a few days Greasy, foul-smelling stools that float (steatorrhoea) suggesting fat malabsorption Stool changes accompanied by unexplained weight loss, fever, or night sweats Severe or persistent diarrhoea (more than seven days) or constipation unresponsive to usual measures It is particularly important to report stool changes if you have a history of gallbladder disease, pancreatitis, or inflammatory bowel conditions
